Guardian Pharmacy Services (GRDN) Cash & Current Investments (2023 - 2026)

Guardian Pharmacy Services has reported Cash & Current Investments for 4 years, with the latest figure at $64.9 million in Q1 2026.

• Quarterly Cash & Current Investments rose 363.55% year-over-year to $64.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.9 million (up 363.55% YoY) and the FY2025 annual result came in at $65.6 million, up 1308.13% from the prior year.
• Cash & Current Investments slipped to $64.9 million in Q1 2026 per GRDN's latest filing, from $65.6 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $65.6 million in Q4 2025 and troughed at $752000.0 in Q4 2023.
• A 4-year average of $30.3 million and a median of $27.7 million in 2025 frame the typical range for Cash & Current Investments.
• The widest YoY moves for Cash & Current Investments: up 1308.13% in 2025, down 1.97% in 2025.
• Over 4 years, Cash & Current Investments stood at $752000.0 in 2023, then surged by 519.68% to $4.7 million in 2024, then soared by 1308.13% to $65.6 million in 2025, then declined by 1.11% to $64.9 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $64.9 million, $65.6 million, and $36.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.